orciprenaline [6019]



orciprenaline


SMILES CC(C)NCC(O)c1cc(O)cc(O)c1
InChIKey LMOINURANNBYCM-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 4
Hydrogen bond donors 4
Rotatable bonds 4
Log P 1.129
Molecular weight (Da) 211.1
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

orciprenaline


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations β2


Compound is not listed as a drug.